Chemed Corp. (NYSE:CHE) Director Patrick P. Grace sold 500 shares of the firm’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $201.48, for a total value of $100,740.00. Following the transaction, the director now owns 4,515 shares of the company’s stock, valued at $909,682.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Chemed Corp. (NYSE:CHE) traded up 0.72% during mid-day trading on Monday, hitting $203.50. The stock had a trading volume of 76,903 shares. Chemed Corp. has a 12-month low of $132.92 and a 12-month high of $216.01. The company’s 50 day moving average price is $193.25 and its 200 day moving average price is $196.09. The stock has a market cap of $3.25 billion, a P/E ratio of 50.48 and a beta of 1.13.

Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.26. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The company had revenue of $415.06 million during the quarter, compared to analyst estimates of $407.56 million. During the same quarter in the prior year, the business earned $1.80 earnings per share. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. Equities research analysts predict that Chemed Corp. will post $8.21 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/02/patrick-p-grace-sells-500-shares-of-chemed-corp-che-stock.html.

A number of institutional investors have recently made changes to their positions in CHE. USA Financial Portformulas Corp acquired a new stake in Chemed Corp. in the 2nd quarter valued at $292,000. Dynamic Technology Lab Private Ltd purchased a new position in Chemed Corp. in the second quarter valued at about $648,000. Piedmont Investment Advisors LLC purchased a new position in Chemed Corp. in the second quarter valued at about $711,000. Kalos Management Inc. raised its position in Chemed Corp. by 0.7% in the second quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock valued at $1,333,000 after purchasing an additional 45 shares during the period. Finally, Coldstream Capital Management Inc. purchased a new position in Chemed Corp. in the second quarter valued at about $229,000. 96.96% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have issued reports on CHE shares. Zacks Investment Research lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Royal Bank Of Canada reissued a “hold” rating and issued a $209.00 price objective on shares of Chemed Corp. in a research note on Monday, July 31st. BidaskClub lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. KeyCorp initiated coverage on shares of Chemed Corp. in a report on Monday, August 28th. They issued a “sector weight” rating for the company. Finally, TheStreet cut shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Three investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $215.00.

About Chemed Corp.

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Insider Buying and Selling by Quarter for Chemed Corp. (NYSE:CHE)

Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.